Former Medtronic (NYSE:MDT) CEO William George said last week that the CEOs of corporate America can have a larger impact than the U.S. Congress when it comes to gun control.
“All of Congress is afraid of the NRA, so I’m worried about getting something done there,” George told CNBC last week. “CEOs can do a lot more locally, in organizing coalitions among mayors, governors, state legislators and coalitions of business people and educators – school boards – to make something happen locally.
“Frankly I’d like to get rid of the assault weapons myself,” he said, adding that the Trump administration’s proposal to arm teachers “is a crazy idea.”
“If a few shareholders object, so be it,” said George, who led the medical device-making giant from 1991 to 2001. “These are our employees’ children. These are part of our companies’ families. We want to make sure they’re safe, otherwise people are not going to come to work for our companies and live in our communities. They have to be in a safe environment. It’s inexcusable.”
And although such a morality-based stance could turn off some investors, he noted, “the companies that do that are going to perform. If your only purpose is making money, you’re going to run, ultimately, into difficulties.”
“This is what inspires your employees. This is what motivates them, that inspires your customers. You’re creating a larger family,” George said.
The post Ex-Medtronic chief George: CEOs can do more on gun control appeared first on MassDevice.
from MassDevice http://ift.tt/2FzRCSr
The U.S. Patent Trial and Appeal Board ruled last week that the tribal immunity granted to Native American tribes in the U.S. does not shield tribes from patent challenges.
Boston Scientific
You may think your team has covered all the bases when it comes to protecting the safety of human subjects in your clinical trial. You have a team of monitors in place to review reports and ensure your trial follows safety protocols. However, every trial needs a system of checks and balances.